- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03904615
Geriatric Recovery Using Inpatient and Post-hospitalization Supplementation (GRIPS)
July 25, 2023 updated by: The University of Texas Medical Branch, Galveston
A Phase I Randomized Clinical Trial of In-hospital and Post-hospital Whey Protein vs. Low Quality Protein vs. Isocaloric Placebo Supplementation to Improve Recovery From Hospitalization in Older Adults
The purpose of the study is to determine the feasibility of nutritional interventions designed to help older patients maintain physical function after being in the hospital.
We will test the feasibility and effect of nutritional interventions with whey protein, collagen or placebo on functional recovery from hospitalization in community dwelling older adults.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
We will compare in a randomized parallel design double blind pilot phase I study the feasibility of whey protein vs. collagen vs. isocaloric placebo supplementation in older adults during an acute hospitalization for a medical condition, and the treatments' effect size on physical function after hospital discharge.
Study Type
Interventional
Enrollment (Estimated)
160
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Erin Hommel, MD
- Phone Number: 4092669669
- Email: erhommel@utmb.edu
Study Contact Backup
- Name: Shawn Goodlett
- Phone Number: 4092667590
- Email: smgoodle@utmb.edu
Study Locations
-
-
Texas
-
Galveston, Texas, United States, 77550
- Recruiting
- UTMB Acute Care for Elders Unit
-
Principal Investigator:
- Elena Volpi, MD, PhD
-
Contact:
- Erin Hommel, MD
- Email: erhommel@utmb.edu
-
Galveston, Texas, United States, 77555
- Recruiting
- Jennie Sealy Hospital
-
Contact:
- Erin R Hommel, MD
- Email: erhommel@utmb.edu
-
Contact:
- Roxana M Hirst, MS
- Phone Number: 4092669641
- Email: rmhirst@utmb.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Aged 65 years or older.
- Admitted to UTMB hospital for any acute medical condition
- English speaking
Exclusion Criteria:
- Inability to consent
- Bed or wheelchair bound prior to hospitalization
- Estimated creatinine clearance 20 ml/min or less, or end stage renal disease not on dialysis
- AST/ALT 2.5 times above the normal limit
- Active cancer
- Palliative care/Hospice
- Estimated protein intake >1.2 g/kg/day during the previous 24 hours
- Any other condition or event considered exclusionary by the PI and faculty physician
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Whey Protein
30 g of whey protein twice daily during hospitalization and for 30 days after discharge
|
30 g of whey protein in flavored water, twice daily, during hospitalization and for 30 days post-discharge
|
Active Comparator: Collagen Protein
30 g of collagen protein twice daily during hospitalization and for 30 days after discharge
|
30 g of collagen protein in flavored water, twice daily, during hospitalization and for 30 days post-discharge
|
Placebo Comparator: Placebo
30 g of maltodextrin twice daily during hospitalization and for 30 days after discharge
|
30 g of maltodextrin in flavored water, twice daily, during hospitalization and for 30 days post-discharge
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical Function
Time Frame: Change from baseline to 30 days after discharge
|
Short Physical Performance Battery (SPPB) scale, 0-12 points.
0=disabled; 12=high performance
|
Change from baseline to 30 days after discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Elena Volpi, MD, PhD, UTMB
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 19, 2019
Primary Completion (Estimated)
March 31, 2024
Study Completion (Estimated)
March 31, 2025
Study Registration Dates
First Submitted
April 4, 2019
First Submitted That Met QC Criteria
April 4, 2019
First Posted (Actual)
April 5, 2019
Study Record Updates
Last Update Posted (Actual)
July 27, 2023
Last Update Submitted That Met QC Criteria
July 25, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 18-0247
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
No.
This is a small Phase 1 feasibility pilot study.
Risk of loss of confidentiality
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
Radboud University Medical CenterNot yet recruitingAging | Aging Well | Immuno Aging
-
TruDiagnosticBlushield USANot yet recruitingAging | Aging Well
-
San Diego State UniversityCompleted
-
Lithuanian Sports UniversityCompletedAging | Healthy AgingLithuania
-
University of Santiago de CompostelaEuropean Regional Development Fund; Center for Industrial Technological Development...Completed
-
Northumbria UniversityUniversity of East AngliaSuspendedSleep | Aging | Healthy AgingUnited Kingdom
-
Amazentis SAproDERM GmbHCompleted
-
University of West AtticaNot yet recruiting
-
University of Santiago de CompostelaAgencia Estatal de Investigación, SpainRecruiting
Clinical Trials on Whey Protein
-
The University of Texas Medical Branch, GalvestonMeiji Co., Ltd.Completed
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); University of California, Davis and other collaboratorsCompletedRegulation of Muscle Protein SynthesisCanada
-
Musclegen Research, Inc.CompletedAbsorption; Disorder, Protein | Analysis, Event History
-
University of NottinghamCompletedAssessing the Impact of "Super-whey" vs. Isonitrogenous Whey on Muscle Protein Synthesis (ARLA-WHEY)SarcopeniaUnited Kingdom
-
Skidmore CollegeCompletedObesity | OverweightUnited States
-
Hospital de Clinicas CaracasTel Aviv UniversityUnknownType 2 DiabetesIsrael, Venezuela
-
KU LeuvenRousselot BVBACompletedHealthy Male Subjects | ExerciseBelgium
-
University of AberdeenCompletedMetabolism Disorder, GlucoseUnited Kingdom
-
McMaster UniversityNestec Ltd.; Australian Institute of Sport; RMIT UniversityCompleted
-
Peking Union Medical College HospitalNot yet recruiting